Alcon AG Cash Flow Conversion Efficiency

Latest as of December 2025: 0.030x

Alcon AG cash flow conversion efficiency. Based on the latest financial reports, Alcon AG (ALC) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF661.33 Million ≈ $836.10 Million USD) by net assets (CHF22.02 Billion ≈ $27.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Alcon AG (2015–2025)

Cash flow conversion efficiency of Alcon AG from 2015 to 2025. This chart illustrates how Alcon AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ALC share price today for real-time trading data and today's change.

Alcon AG Cash Flow Conversion Ratio Explained

Alcon AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Alcon AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alcon AG ranked by their cash flow conversion efficiency. Also see market value of Alcon AG for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Ameren Corp
NYSE:AEE
0.056x
Pembina Pipeline Corp
TO:PPL
0.019x
EMCOR Group Inc
NYSE:EME
0.000x
STMicroelectronics NV ADR
NYSE:STM
0.029x
Prudential plc
F:PRU2
0.031x
Cheniere Energy Partners LP
NYSE:CQP
11.667x
Everpure, Inc.
NYSE:P
0.125x
Iron Mountain Incorporated
NYSE:IRM
-0.440x

Annual Cash Flow Conversion Efficiency for Alcon AG (2015–2025)

The table below shows the annual cash flow conversion efficiency of Alcon AG from 2015 to 2025. Review free cash flow generation of Alcon AG to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF22.02 Billion
≈ $27.84 Billion
CHF2.38 Billion
≈ $3.01 Billion
0.108x +12.11%
2024-12-31 CHF21.55 Billion
≈ $27.25 Billion
CHF2.08 Billion
≈ $2.63 Billion
0.096x +43.19%
2023-12-31 CHF20.62 Billion
≈ $26.07 Billion
CHF1.39 Billion
≈ $1.75 Billion
0.067x +8.81%
2022-12-31 CHF19.68 Billion
≈ $24.88 Billion
CHF1.22 Billion
≈ $1.54 Billion
0.062x -11.45%
2021-12-31 CHF19.26 Billion
≈ $24.34 Billion
CHF1.34 Billion
≈ $1.70 Billion
0.070x +59.74%
2020-12-31 CHF18.82 Billion
≈ $23.80 Billion
CHF823.00 Million
≈ $1.04 Billion
0.044x -8.26%
2019-12-31 CHF19.30 Billion
≈ $24.40 Billion
CHF920.00 Million
≈ $1.16 Billion
0.048x -18.41%
2018-12-31 CHF19.52 Billion
≈ $24.67 Billion
CHF1.14 Billion
≈ $1.44 Billion
0.058x +10.45%
2017-12-31 CHF23.03 Billion
≈ $29.11 Billion
CHF1.22 Billion
≈ $1.54 Billion
0.053x -2.24%
2016-12-31 CHF23.01 Billion
≈ $29.09 Billion
CHF1.25 Billion
≈ $1.57 Billion
0.054x -6.66%
2015-12-31 CHF23.64 Billion
≈ $29.88 Billion
CHF1.37 Billion
≈ $1.73 Billion
0.058x --

About Alcon AG

SW:ALC Switzerland Medical Instruments & Supplies
Market Cap
$36.42 Billion
CHF28.81 Billion CHF
Market Cap Rank
#883 Global
#15 in Switzerland
Share Price
CHF59.10
Change (1 day)
+0.58%
52-Week Range
CHF48.75 - CHF67.06
All Time High
CHF84.68
About

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other product… Read more